Adults with chronic hives unresponsive to antihistamines may soon have a new, FDA-approved prescription option.
Live Poll
Do you believe new pharmaceutical treatments for chronic skin conditions will improve your overall quality of life?
October 7, 2026
Measles Outbreaks Have Continued Across U.S.Cases continue to spread in parts of the Heartland, affecting thousands of unprotected individuals.
October 7, 2026
FDA Expanded Leniolisib Use for Children With APDSChildren aged 4 to 11 can now access this targeted therapy for the rare genetic immune condition.
October 6, 2026
FDA Identified IGIV Lot Linked to Hypersensitivity ReactionsThe FDA is investigating reports of severe reactions in patients who received a specific lot of immune globulin.
October 6, 2026
Anatool Tool Has Improved Anaphylaxis Clinical SupportClinicians can use this new digital tool to help identify anaphylaxis and manage weight-based epinephrine dosing.
October 6, 2026
Gut Protein Deficiency Linked to Peanut Allergy RiskResearchers identified a key enzyme deficiency in the gut that may influence peanut allergy susceptibility in children.
October 5, 2026
Pediatricians Have Called for Raw Dairy Sales BanThe American Academy of Pediatrics says unpasteurized milk poses serious risks to children and pregnant individuals.
October 5, 2026
First Interchangeable Biosimilar for Asthma LaunchedThe U.S. launch of OMLYCLO offers a new option for patients managing asthma and several allergic conditions.
October 4, 2026
Omega-3 Supplements Linked to Cognitive ADHD GainsA new meta-analysis suggests these fatty acids may improve cognitive test performance in children with ADHD.
October 3, 2026
Ultra-Low-Dose Therapy Aided Severe Nut AllergiesChildren with high-sensitivity nut allergies used a gradual induction approach to transition toward conventional treatment.
October 1, 2026
Half of Atopic Dermatitis Patients Left Prescriptions UnfilledA 2026 report found that despite a formal diagnosis, many patients with eczema do not access prescribed treatments.
